KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) Short-Term Debt issuances (2017 - 2026)

Johnson & Johnson's Short-Term Debt issuances history spans 18 years, with the latest figure at $12.4 billion for Q1 2026.

  • On a quarterly basis, Short-Term Debt issuances rose 41.61% to $12.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $18.2 billion, a 2.96% decrease, with the full-year FY2025 number at $14.6 billion, down 4.52% from a year prior.
  • Short-Term Debt issuances hit $12.4 billion in Q1 2026 for Johnson & Johnson, up from $3.9 billion in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for JNJ hit a ceiling of $14.9 billion in Q1 2023 and a floor of -$2.0 billion in Q3 2024.
  • Historically, Short-Term Debt issuances has averaged $4.9 billion across 5 years, with a median of $3.3 billion in 2024.
  • Biggest five-year swings in Short-Term Debt issuances: skyrocketed 13026.09% in 2022 and later crashed 926.56% in 2024.
  • Tracing JNJ's Short-Term Debt issuances over 5 years: stood at $3.0 billion in 2022, then tumbled by 57.57% to $1.3 billion in 2023, then soared by 157.06% to $3.3 billion in 2024, then increased by 18.83% to $3.9 billion in 2025, then skyrocketed by 217.89% to $12.4 billion in 2026.
  • Business Quant data shows Short-Term Debt issuances for JNJ at $12.4 billion in Q1 2026, $3.9 billion in Q4 2025, and $1.3 billion in Q3 2025.